Delay in diagnosis and treatment of squamous cell carcinoma of the skin

Acta Dermato-Venereologica

Volumn 90, Issue 6, 2010, Pages 595-601

  Renzi, Cristina ^a   Mastroeni, Simona ^a   Manoranparampi, Thomas J ^a   Pasarelli, Francesca ^a   Caggiati, Alessio ^a   Potenza, Clemente ^a   Pasquini, Paolo ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Cutaneous; Delay; Skin cancer; Squamous cell carcinoma

Indexed keywords

AGED; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; CRYOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PHYSICIAN; PRIORITY JOURNAL; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; THERAPY DELAY;

AGED; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; DELAYED DIAGNOSIS; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PATIENT ACCEPTANCE OF HEALTH CARE; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78649692275     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0966     Document Type: Article

References (28)

1. Gray DT, Suman VJ, Su WP, Clay RP, Harmsen WS, Roenigk RK. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984-1992. Arch Dermatol 1997; 133: 735-750.
2. Rudolph R, Zelac D. Squamous cell carcinoma of the skin. Plast Reconstr Surg 2004; 114: 82-94.
3. Alam M, Ratner D. Cutaneous squamous cell carcinoma. N Engl J Med 2001; 344: 975-983.
4. Housman T, Feldman SR, Williford PM, Fleisher AB, Goldman ND, Acostamadiedo JM. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003; 48: 425-429.
5. Chen JG, Fleischer AB, Smith ED, Kancler C, Goldman ND, Williford PM, et al. Cost of non-melanoma skin cancer treatment in the United States. Dermatol Surg 2001; 27: 1035-1038.
6. Brantsch KD, Meisner C, Schoenfisch B, Trilling B, Wehner-Caroli J, Roecken M, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008; 9: 713-720.
7. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg 2002; 28: 268-273.
8. Rowe D, Carroll R, Day C. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol 1992; 26: 976-990.
9. Renzi C, Mastroeni S, Passarelli F, Manoooranparampil TJ, Caggiati A, Potenza C, et al. Factors associated with large cutaneous squamous cell carcinomas. J Am Acad Dermatol 2010; 63: 404-411.
10. Cassileth BR, Temoshok L, Frederick BE, Walsh WP, Hurwitz S, Guerry D, et al. Patient and physician delay in melanoma diagnosis. J Am Acad Dermatol 1988; 18: 591-598.
11. Richard MA, Grob JJ, Avril MF, Delaunay M, Gouvernet J, Wolkenstein P, et al. Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer 2000; 89: 271-279.
12. Richard MA, Grob JJ, Avril MF, Delaunay M, Gouvernet J, Wolkenstein P, et al. Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer 2000; 89: 280-285.
13. Betti R, Vergani R, Tolomio E, Santambrogio R, Crosti C. Factors of delay in the diagnosis of melanoma. Eur J Dermatol 2003; 13: 183-188.
14. Blum A, Brand CU, Ellwanger U, Schlagenhauff B, Stroebel W, Rassner G, et al. Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment. Br J Dermatol 1999; 141: 783-787.
15. Blum A, Ingvar C, Avramidis M, van Kannen A, Menzies SW, Olsson H, et al. Time to diagnosis of melanoma: same trend in different continents. J Cutan Med Surg 2007; 11: 137-144.
16. Baade PD, English DR, Youl PH, McPherson M, Elwood JM, Aitken JF. The relationship between melanoma thickness and time to diagnosis in a large population-based study. Arch Dermatol 2006; 142: 1422-1427.
17. Oliveria SA, Christos PJ, Halpern AC, Fine JA, Barnhill RL, Berwick M. Patient knowledge, awareness, and delay in seeking medical attention for malignant melanoma. J Clin Epidemiol 1999; 52: 1111-1116.
18. Eide MJ, Weinstock MA, Dufresne RG, Neelagaru S, Risica P, Burkholder GJ, et al. Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin). J Invest Dermatol 2005; 124: 308-314.
19. Renzi C, Mastroeni S, Manoooranparampil TJ, Passarelli F, Caggiati A, Pasquini P. Skin cancer knowledge and preventive behaviors among patients with a recent history of cutaneous squamous cell carcinoma. Dermatology 2008; 217: 74-80.
20. Porta M. A dictionary of epidemiology. New York: Oxford University Press, Inc., 2008: p. 257.
21. Schwartz RA, Stoll HL. Squamous cell carcinoma. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen K, editors. Dermatology in general medicine, 4th edn. New York: McGraw-Hill, Inc., 1993: p. 827-832.
22. Bhawan J. Squamous cell carcinoma in situ in skin: what does it mean? J Cutan Pathol 2007; 34: 953-955.
23. The NCCN Basal Cell and Squamous Cell Skin Cancers Clinical Practice Guidelines in Oncology (Version 1.2008). [accessed November 2009] National Comprehensive Cancer Network, Inc. Available from: http://www.nccn.org.
24. Swetter SM, Soon S, Harrington CR, Chen SC. Effect of healthcare delivery models on melanoma thickness and stage in a university-based referral center. Arch Dermatol 2007; 143: 30-36.
25. Jagdeo J, Weinstock MA, Piepkorn M, Bingham SF. Reliability of the histophatologic diagnosis of keratinocyte carcinomas. J Am Acad Dermatol 2007; 57: 279-284.
26. Ackerman AB, Mones J. Squamous-cell carcinoma in situ is a fiction! J Cutan Pathol 2009; 36: 74-75.
27. Clouser MC, Harris RB, Roe DJ, Saboda K, Ranger-Moore J, Duckett L, et al. Risk group, skin lesion history, and sun sensitivity reliability in squamous cell skin cancer progression. Cancer Epidemiol Biomarkers Prev 2006; 15: 2292-2297.
28. Ming ME, Levy RM, Hoffstad OJ, Filip JF, Gimotty PA, Margolis DJ. Validity of patient self-reported history of skin cancer. Arch Dermatol 2004; 140: 730-735.